Basit öğe kaydını göster

dc.contributor.authorBesisik, Fatih
dc.contributor.authorOkten, Atilla
dc.contributor.authorCakaloglu, Yylmaz
dc.contributor.authorMungan, Zeynel
dc.contributor.authorOzdil, Sadakat
dc.contributor.authorCevikbas, Ugur
dc.contributor.authorBoztas, Gungor
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorDemir, Kadir
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorAksoy, Nevzat
dc.contributor.authorPoturoglu, Sule
dc.contributor.authorAkyuz, Umit
dc.date.accessioned2021-03-06T20:33:06Z
dc.date.available2021-03-06T20:33:06Z
dc.date.issued2007
dc.identifier.citationDemir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., Akyuz U., Besisik F., Boztas G., Mungan Z., et al., "What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?", Annals of Hepatology, cilt.6, ss.92-96, 2007
dc.identifier.issn1665-2681
dc.identifier.otherav_fabac8d5-9eff-4b69-ac20-a862b7effd6a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/164158
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34249948857&origin=inward
dc.identifier.urihttps://doi.org/10.1016/s1665-2681(19)31938-6
dc.description.abstractBackground and study aims: Increased alanine aminotransferase (ALT) levels with negative hepatitis B virus (HBV) DNA by hybridization is a common problem in Turkey where is a mild endemic region. We aimed to evaluate the causes of elevated ALT levels in patients who are negative for hepatitis B e antigen (HBeAg) and HBV DNA (by hybridization) for at least 6 months. Patients-methods: Forty-nine patients were enrolled in this study. Histological changes [histological activity index (HAI), and the extent of fibrosis] were assessed according to the Knodell scoring system and steatosis were graded by Brunt's classification for NAFLD in all patients. Results: A mean age of the patients was 34.9 +/- 12.1 years (16-70). 43 (87.8%) of them were male. Mean ALT level was 95 +/- 39.7 IU/L (50-258). Hyperglycemia (>100 mg/dL) and hyperlipidemia were found in 12 and 24 patients, respectively. Hepatic steatosis (7 patients grade 1; 5 patients grade 2; and 7 patients grade 3), ground-glass hepatocyte, chronic hepatitis, and Wilson disease were found in liver biopsy in 38.8 %, 32.6 %, 26.6 %, 2 %, respectively. Mean HAI was 6.5 +/- 3.6 (4-12) in chronic hepatitis. Seven patients (53.9%) were in stage I and 2 while 6 patients (46.1 %) were in stage 3 and 4. Conclusions: Nonalcoholic fatty liver disease is the most common cause of elevated ALT levels in HBeAg negative/HBV DNA negative patients. Chronic hepatitis B was found in 26.6 % of these patients.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleWhat is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
dc.typeMakale
dc.relation.journalAnnals of Hepatology
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume6
dc.identifier.issue2
dc.identifier.startpage92
dc.identifier.endpage96
dc.contributor.firstauthorID182280


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster